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Epigenetic silencing of the c-fms locus during
B-lymphopoiesis occurs in discrete steps
and is reversible
Hiromi Tagoh1, Alexandra Schebesta2,
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David Hume3, Meinrad Busslinger2
and Constanze Bonifer1,*
1Molecular Medicine Unit, St James’s University Hospital, University of
Leeds, Leeds, UK, 2Research Institute of Molecular Pathology, Vienna
Biocenter, Vienna, Austria and 3Institute for Molecular Bioscience,
University of Queensland, Queensland, Australia
The murine c-fms (Csf1r) gene encodes the macrophage
colony-stimulating factor receptor, which is essential for
macrophage development. It is expressed at a low level in
haematopoietic stem cells and is switched off in all non-
macrophage cell types. To examine the role of chromatin
structure in this process we studied epigenetic silencing of
c-fms during B-lymphopoiesis. c-fms chromatin in stem
cells and multipotent progenitors is in the active confor-
mation and bound by transcription factors. A similar
result was obtained with specified common myeloid and
lymphoid progenitor cells. In developing B cells, c-fms
chromatin is silenced in distinct steps, whereby first
the binding of transcription factors and RNA expression
is lost, followed by a loss of nuclease accessibility.
Interestingly, regions of de novo DNA methylation in B
cells overlap with an intronic antisense transcription unit
that is differently regulated during lymphopoiesis.
However, even at mature B cell stages, c-fms chromatin
is still in a poised conformation and c-fms expression can
be re-activated by conditional deletion of the transcription
factor Pax5.
The EMBO Journal (2004) 23, 4275–4285. doi:10.1038/
sj.emboj.7600421; Published online 14 October 2004
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Introduction
During haematopoietic differentiation, haematopoietic stem
cells (HSCs) become gradually restricted in their differentia-
tion potential. The balanced formation of the different blood
cell types therefore requires the activation of genes in appro-
priate cells as well as the silencing of genes in cells in which
expression is undesired (Hu et al, 1997; Miyamoto et al, 2002;
Smale, 2003). Blood cell growth and differentiation are
regulated by specific cytokines, which act on cells expressing
particular combinations of lineage-specific cytokine receptors.
Because the cytokine requirement for precursor cells is different
from that of mature cells, it is important to render cells of one
lineage unresponsive to the cytokines regulating alternative
lineage cells. Cell type-specific inhibitors of cytokine receptor
signalling have been characterized (reviewed in Fujimoto and
Naka, 2003), but little is known about how cytokine receptor
gene expression is silenced at the epigenetic level.
Once a cell is committed to differentiate towards a parti-
cular lineage, it responds to lineage-specific signals and
generally cannot alter its cell fate. However, certain types of
apparently committed cells still have the potential to differ-
entiate into cells of another lineage (reviewed in Graf, 2002).
The importance of cytokine signals in lineage determination
was emphasized by a series of experiments using transgenic
mice expressing the human interleukin (IL)-2 receptor b or
granulocyte–macrophage colony-stimulating factor (GM-CSF)
receptor in haematopoietic progenitors (Kondo et al, 2000;
Iwasaki-Arai et al, 2003). These experiments showed that
purified common lymphoid progenitors (CLPs) and pro-T
cells from these mice can be converted by alternative cyto-
kine signalling into myeloid cells. Lineage switching was also
found in murine pro-B cells ectopically expressing the human
macrophage colony-stimulating factor (CSF-1) receptor
(c-fms) gene (Borzillo et al, 1990). Such manipulated cells
can differentiate to macrophages in response to CSF-1. This
alternative differentiation is suppressed by IL-7 signalling,
which suggests that signals through the CSF-1 and IL-7
receptors can play an instructive role in myeloid and lym-
phoid differentiation, respectively.
Expression of the c-fms gene is tightly controlled. c-fms
mRNA is detected in HSCs at a low level and is upregulated
during macrophage differentiation. Receptor protein expres-
sion on the surface of the cells is only found on committed
macrophage precursors (Tagoh et al, 2002). Tissue-specific
mRNA expression of c-fms is regulated by well-studied pro-
moter and intronic enhancer elements (Figure 1). The pro-
moter used in macrophages is a TATA-less myeloid promoter,
with multiple purine-rich elements bound by Ets family
transcription factors, notably PU.1 (Yue et al, 1993; Ross
et al, 1998). Tissue-restricted expression of the gene is
dependent on the c-fms intron regulatory element or FIRE
(Himes et al, 2001; Sasmono et al, 2003). We have previously
examined the mechanism of upregulation of c-fms expression
during macrophage differentiation. We showed that the c-fms
promoter is already occupied by transcription factors at the
stage of common myeloid progenitors (CMPs) where only a
low level of transcripts is detected. During macrophage
differentiation, c-fms expression is regulated by the coordi-
nated assembly and disassembly of transcription factor com-
plexes on FIRE (Tagoh et al, 2002). c-fms cis-elements in
macrophages show a high level of histone acetylation, but
associate with both positive and negative chromatin modifi-
cation activities (Follows et al, 2003).
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c-fms expression is silenced in non-macrophage cells.
Silencing of c-fms mRNA in B lymphocytes is dependent on
the presence of the transcription factor Pax5 (Nutt et al,
1999). Interestingly, conditional inactivation of Pax5 in com-
mitted B cell precursors leads to derepression of the c-fms
gene (Mikkola et al, 2002). This is also observed after over-
expression of the myeloid transcription factors C/EBP a and b
in B cells (Xie et al, 2004). However, the chromatin structure
of c-fms in B cells with which these transcription factors
interact and the mechanism of derepression are essentially
unknown. Silencing of macrophage-specific genes during
B-lymphopoiesis is not well understood and may not be
straightforward, as B cells and macrophages share a number
of different transcription factors such as PU.1. To address this
issue, we have examined the chromatin alterations occurring
during the silencing of c-fms expression in B cell develop-
ment. We show that the chromatin at cis-regulatory regions of
the c-fms locus is in an active conformation and is bound by
transcription factors in stem cells and early precursor cells.
Epigenetic silencing of c-fms during B-lymphopoiesis occurs
in distinct steps, but even in mature B cells c-fms chromatin
is still in a poised conformation. This is confirmed by our
finding that de novo DNA methylation is increased in T cells,
but is delayed in B cell development whereby the promoter
and FIRE remain unmethylated throughout. We show that
such a poised chromatin conformation correlates with the
potential to re-activate c-fms expression even in purified
mature B cells by conditional deletion of Pax5. An important
finding of this study is that regions of de novo DNA methyla-
tion in lymphoid cells overlap with an intronic antisense (AS)
transcription unit that is active in committed B cells and
macrophages, but not in cells where c-fms is completely shut
down.
Results
The c-fms promoter and FIRE bind transcription factors
in pluripotent stem cells and common lymphoid
progenitor cells but not in differentiated B cell
populations
Expression of c-fms mRNA is detectable in HSCs and CMPs
(Miyamoto et al, 2002; Tagoh et al, 2002), but is absent in
pro-B cells (Nutt et al, 1999). To define the first steps in c-fms
silencing, we asked whether transcription factor occupancy
on c-fms in stem cells is complete and thus indicative of a
primed chromatin structure. Secondly, because restricted
lymphoid progenitor cells (CLPs) were shown to possess
latent myeloid differentiation potential (Kondo et al, 2000;
Iwasaki-Arai et al, 2003), we examined whether c-fms was
still occupied by transcription factors. We addressed these
questions by studying purified LinSca1þc-Kithi (LSK) cells,
which were highly enriched for HSCs and short-term recon-
stituting stem cells (Geiger et al, 1998; Adolfsson et al, 2001),
CLPs (Kondo et al, 1997) and CMPs (Akashi et al, 2000;
Tagoh et al, 2002). As a control, we examined purified pro-B
cells from the bone marrow of RAG2/ mice and mature
bone marrow-derived macrophages. The purity of each po-
pulation was confirmed by surface marker analysis, Giemsa
staining, colony assays and mRNA expression analysis
(Figure 2 and Supplementary Figures 1 and 2; data not
shown). Purified cells displayed distinct in vitro differentia-
tion potentials (Figure 2A). As described previously, LSKs
and CMPs mostly generated myeloid colonies (Akashi et al,
2000). CLPs generated lymphoid colonies containing B and
NK cells but no myeloid cells, as confirmed by FACS analysis
of CD19, NK1.1 and CD11b expression (data not shown). The
CLP fraction formed in average one GM colony in 1000 cells,
which was probably derived from a low-level contamination
with myeloid precursors. Clonogenicity of CLPs under lym-
phoid assay conditions was much lower than that of myeloid
progenitors under myeloid assay conditions, the latter reg-
ularly produced at least 250 colonies from 1000 cells (Tagoh
et al, 2002 and this study). The expression profile of selected
genes in purified restricted progenitors confirmed the identity
of these cells (Akashi et al, 2000; DeKoter and Singh 2000;
Supplementary Figure 1). mRNA for the myeloid-specific
lysozyme M gene was only detected at trace levels in CLPs
(Supplementary Figure 3A), confirming that this cell popula-
tion had negligible myeloid contamination.
The result of our c-fms expression studies is shown in
Figure 2B. c-fms transcripts were found around the detection
limit in purified primary pro-B cells. In contrast, all other
precursor cell types (LSKs, CLPs and CMPs) expressed low
but clearly detectable levels of c-fms RNA. The low level of
Promoter FIRE-1kb
−2000 −1000 +1000 +2000 +3000 +4000ATG
FIRE
(enhancer)
DNaseI hypersensitive sites
Conserved regulatory sequences
bp
ChIP assay
DNA methylation
analysis
+6000
Exons
Figure 1 Map of the c-fms regulatory region. DHSs present in macrophages are shown as vertical arrows. Numbers indicate the nucleotide
position relative to the ATG start codon. Grey boxes represent exons, and black boxes show regions conserved between human and mouse. The
main transcription start sites are indicated as horizontal arrows. Amplicons for ChIP assays and DNA methylation analysis are indicated.
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GM colony formation of the CLP fraction (less than 1%
compared with CMPs) was not reflected at the level of
c-fms expression (20% of that of CMPs). These results were
mirrored by transcription factor-binding site occupancy as
revealed by in vivo DMS footprinting analysis with these cell
populations. As shown in Figure 3, the PU.1 consensus
sequences within the promoter and FIRE were occupied in
LSKs, CLPs and CMPs. The footprints seen at the promoter
were weaker in CLPs than in LSKs, CMPs or macrophages,
whereas the footprints at FIRE were similar in both CLPs and
CMPs. In contrast, the Ets/AML1/Sp1 cluster in FIRE was
only occupied in CLPs, CMPs and mature myeloid cells. To
further rule out the possibility of myeloid contamination, we
performed a DMS footprinting experiment on a sample con-
sisting of a mixture of 95% wild-type pro-B cells (lacking
footprints) and 5% monocytic cells (with fully occupied
transcription factor-binding sites). RNA prepared from this
cell mixture contained a much higher level of lysozyme M
RNA than CLPs (Supplementary Figure 3A), but showed no
footprints at the promoter and FIRE (Supplementary Figure
3B and C). This confirms that the threshold for detecting
alterations of DMS reactivity in mixed cell populations is
significantly higher than any possible myeloid contamina-
tion. In summary, although purified CLPs were functionally
distinct from CMPs and could not generate myeloid cells,
c-fms chromatin in these cells is accessible to transcription
factor binding, resulting in low level but clearly detectable
c-fms mRNA expression. No footprints on any of the c-fms cis-
regulatory elements were seen in pro-B cells, confirming that
the loss of steady-state mRNA is accompanied by a loss of
stable transcription factor binding in the majority of cells.
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Figure 2 Characterization of purified LSKs, CLPs and CMPs.
(A) Colony-forming activities of LSKs, CLPs and CMPs. Sorted
cells were seeded at a density of 1000 cells/ml in methylcellulose
medium containing IL-7, SCF and VEGF for lymphoid assays (pre-B
cell mix), and IL-3, IL-6, SCF and Epo for myelo-erythroid assays
(GM, M, Mix, BFU-E). Colonies were scored at days 8–10. The
results are represented as the mean value of four independent
experiments. (B) Expression of c-fms mRNA in purified LSKs,
CLPs, CMPs, pro-B cells and macrophages (M^). Gene expression
was measured by RT–PCR. Arbitrary units were calculated relative
to the expression level in CMPs. The bars represent the mean value
of two independent experiments.
Figure 3 Transcription factor binding to the c-fms promoter and
FIRE is lost in pro-B cells. DMS footprinting analysis of promoter
(upper strand) (A) and FIRE (lower strand) (B). The numbers on the
left indicate the nucleotide position relative to the ATG codon.
Transcription factor-binding sites and their nature as determined
by ChIP assays and in vitro DNA–protein interaction studies (Tagoh
et al, 2002; Follows et al, 2003) are indicated. Black circles indicate
hypermethylated guanines, and open circles indicate hypomethy-
lated guanines compared with DMS-treated naked DNA (G). Grey
circles indicate weaker footprints. From left to right: DMS-treated
naked DNA (G), purified cells (LSKs, CLPs, CMPs, bone marrow
macrophages (M^), freshly purified pro-B cells from RAG2/
mice).
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c-fms chromatin in B cells is still in a poised
conformation
Experiments from our laboratory showed that genes destined
for activation undergo a number of defined chromatin altera-
tions during cell differentiation, which start long before the
onset of gene expression (Kontaraki et al, 2000; Tagoh et al,
2004). If such a stepwise process could be linked to a specific
chromatin fine structure of given genes during gene silencing,
this would enable the definition of windows of opportunity
for the reversion of specific gene expression programmes. We
therefore examined different chromatin features of c-fms
during B-lymphopoiesis as well as in other non-myeloid cell
types and compared them with those of myeloid cells.
A hallmark of active chromatin is its enhanced accessi-
bility to digestion with nucleases. We measured differential
nuclease accessibility in various cell types using DNaseI and
micrococcal nuclease (MNase). Digestion products were vi-
sualized at single nucleotide resolution by using two different
types of ligation-mediated PCR (LM-PCR). DNaseI digestion
followed by amplifying single-strand molecules measures the
number and position of nicks in one DNA strand, thus
assaying both DNA accessibility and DNA topology. MNase
digestion was followed by the selective amplification of
double-strand breaks, which usually occur in nucleosomal
linker regions. The appearance of specific bands in such an
assay is interpreted as an indication for a specifically posi-
tioned nucleosome. To perform these assays we isolated
B220þ bone marrow B cells, consisting mainly of early B
cell precursors and CD19þ splenic B cells consisting mostly
of mature B cells, as indicated in Supplementary Figure 3. In
addition, we assayed primary embryonic fibroblasts, mature
macrophages and purified T cells (Supplementary Figure 3).
Figure 4A shows an MNase digestion experiment examin-
ing nuclease accessibility at the c-fms promoter. To control
for equal digestion efficiency, we also examined the GAPDH
promoter, which is active in every cell type. With fibroblasts
we obtained a rather diffuse cleavage pattern except for
one slightly stronger band upstream of the PU.1-binding
sites at 130 bp just upstream of the main transcription
start sites. Macrophages showed a different digestion pat-
tern. Here we observed a strong MNase hypersensitive site
(MNase HS) downstream of the main transcription start
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Figure 4 Chromatin at the c-fms promoter is in a partially active conformation in B cells. (A) From left to right: In vivo MNase footprinting
experiment with naked DNA and chromatin prepared from the indicated cell populations using primers specific for the c-fms promoter (upper
panel) or the GAPDH promoter (lower panel). Horizontal arrows indicate the position of transcription start sites. The PvuII site is at position
66 bp. (B) In vivo DNaseI footprinting experiment with naked DNA and the indicated cell populations using increasing amounts of DNaseI
(20 and 40 U) G: G-reaction of naked DNA. For further description, see Figure 3.
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sites. Interestingly, we saw the same MNase HS in immature
B cells, although the upstream band was also present. The
same was true for mature B cells, although the intensity of the
MNase HS was reduced compared to the upstream band. In
contrast, the pattern in T cells resembled more that of
fibroblasts, and the MNase HS had almost disappeared.
However, as the naked DNA control showed some preferen-
tial digestion of the MNase HS sequence, we confirmed by
restriction enzyme accessibility assay using PvuII that this
region was indeed differentially accessible to nuclease diges-
tion in macrophage and fibroblast nuclei (Himes et al, 2001;
data not shown).
In DNaseI hypersensitive site (DHS) mapping experiments,
which assay double-strand cuts produced by DNaseI, we
have previously shown that the c-fms promoter is strongly
DNaseI hypersensitive in macrophages but not in fibroblasts
(Himes et al, 2001). More importantly, no DHS was seen in an
IL-7-dependent pro-B cell line (data not shown). Figure 4B
shows the result of a high-resolution DNaseI digestion ex-
periment with the GAPDH promoter as control. c-fms chro-
matin in macrophages was highly accessible across the entire
promoter region, and a pattern was generated that was
similar but not identical to that generated by naked DNA.
DNaseI accessibility in immature B cells was only slightly
reduced as compared to macrophages and was progressively
reduced in mature B cells, T cells and fibroblasts.
Taken together, our experiments demonstrate that
although transcription factors are no longer stably bound,
the chromatin structure at the c-fms promoter in immature B
cells is very similar to that of myeloid cells. Moreover, even in
mature B cells, the region downstream of the main transcrip-
tion start sites was still highly MNase accessible. No cell
population exhibited a DNaseI hypersensitive region at the
exact position of the MNase HS, which therefore most
likely marks the position of linker DNA. A reasonable hypo-
thesis is therefore that the c-fms promoter is occupied by
a nucleosome that adopts alternative average positions in
c-fms-expressing and nonexpressing cells. In B cells, this
nucleosome maintains a position identical to that of myeloid
cells and is only destabilized later in B cell development,
along with gradually increasing chromatin compaction.
Histone modifications at the c-fms locus are altered
in a complex fashion during B-lymphopoiesis
Chromatin activation and silencing are regulated by different
enzymatic activities that modify the N-terminal tails of
histones (Fischle et al, 2003). Histone acetylation is a hall-
mark of active chromatin, whereas the methylation of histone
H3 lysine 9 (K9) is indicative of inactive chromatin.
Moreover, transcription leaves a trail of histone modification
(histone H3 lysine 4 (K4) trimethylation) behind, which has
been interpreted as a ‘memory’ of recent transcriptional
events and can be maintained through several cell genera-
tions (Ng et al, 2003). We examined the level of histone H3
modification at c-fms by chromatin immunoprecipitation
(ChIP) assays using crosslinked chromatin digested with
MNase (Figure 5). Each amplicon was represented at equal
levels in the input DNA (data not shown). We have pre-
viously shown that the activation of c-fms expression in
macrophages is accompanied by hyperacetylation of histone
H3 at each regulatory region (Follows et al, 2003). These data
were obtained with sonicated chromatin and could be repro-
duced by the experiment shown in Figure 5A, thus validating
our experimental approach. The analysis includes examina-
tion of a second conserved region of the c-fms intron, which
is annotated as FIRE-1kb. This sequence is also DNaseI
hypersensitive in macrophages and has enhancer activity in
transient transfection assays (Himes et al, 2001). An elevated
level of H3K9 acetylation was only seen in macrophages and
monocytes, whereas in all other cell types acetylation levels
were low, but were still slightly elevated in immature B cells.
H3K9 dimethylation levels across c-fms were high in fibro-
blasts, but lower in all other cell types (Figure 5B). However,
the c-fms intronic region but not the promoter and down-
stream genomic regions showed increased H3K9 dimethyla-
tion levels in B-lineage cells as compared to myeloid cells.
The result of the analysis of H3K4 trimethylation was surpris-
ing (Figure 5C). Here we saw a high signal at the promoter
Figure 5 Alterations of histone H3 modifications inside and outside
the c-fms regulatory region during B-lymphopoiesis. ChIP assays
using antibodies specific for acetylated H3K9 (A), dimethylated
H3K9 (B) and trimethylated H3K4 (C). The region-specific enrich-
ment by ChIP was examined by real-time PCR using primers
indicated in Figure 1. DNA enrichment was calculated as described
in Materials and methods. Bars represent the mean7s.d. of quanti-
fications from two to four separate immunoprecipitations analysed
in duplicate.
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and downstream regulatory regions not only in macrophages
and monocytes but also in B cell precursors. The H3K4
trimethylation level in the intronic region was as high as in
macrophages.
CpGs at c-fms cis-regulatory regions are unmethylated
in early progenitors and myeloid cells and are
differentially methylated during B- and T-lymphocyte
differentiation
Methylation of CpGs is a hallmark of silent chromatin (Bird,
2002). We therefore examined the DNA methylation status of
selected CpG motifs centrally located within each of the c-fms
cis-elements at the different stages of myeloid cell and B cell
differentiation by using methylation-sensitive restriction en-
zymes. This analysis was performed with LSKs, CMPs, CLPs
pro-B cells, sorted splenic B and thymic T cells as well as
embryonic fibroblasts (Figure 6B and Supplementary Figure
4). The c-fms regions investigated were the promoter, FIRE-
1kb, FIRE and a downstream region ((C); Figure 6A), which
did not harbour a DHS and is not conserved between human
and mouse. The promoter of the silent a-fetoprotein gene
served as additional control. Both genomic regions were fully
methylated in every cell type examined (Figure 6B).
The CpGs at all c-fms cis-elements analysed were highly
methylated in embryonic fibroblasts and completely un-
methylated in macrophages (Figure 6B). CpGs at the promo-
ter (site 1) and FIRE (site 4) showed a similarly low
methylation level in LSKs, CMPs and CLPs. However, the
methylation level of CpGs at the intronic FIRE-1kb (sites 2
and 3) was elevated in CLPs and was further increased with
progressing B cell differentiation. CpG methylation at the
promoter and FIRE remained at low levels during B cell
development. In contrast, CpG methylation levels at the
promoter and FIRE were increased in T cells.
Regions of DNA methylation and increased histone
H3K9 dimethylation overlap with a differentially
regulated antisense transcription unit
As shown above, levels of H3K4 trimethylation were elevated
throughout the intronic regulatory region in B cells. Two
Figure 6 DNA methylation at specific c-fms cis-regulatory elements during haematopoietic differentiation. (A) Schematic representation of the
position of the recognition sites of the differentially methylation-sensitive restriction enzymes MaeII and HpaII in the c-fms promoter and first
intron (1–4: regulatory regions; C: downstream control region). Relevant DNA sequences and the position of transcription factor-binding sites
are depicted in Supplementary Figure 4. (B) DNA methylation status at specific c-fms cis-regulatory (black bars) and control regions (white
bars) in the indicated cell types. After HpaII or MaeII digestion of genomic DNA from each cell type, the amount of undigested DNA was
measured by real-time PCR. The bars represent the mean value7s.d. of two to four independent experiments analysed in duplicate. AFP:
a-fetoprotein promoter.
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explanations were possible for our findings. One was that
H3K4 trimethylation was highly stable and was still present
in B cells, although transcription had ceased. However, H3K4
trimethylation levels at some positions of the c-fms locus
were almost as high in B cells as in macrophages. An
alternative explanation was that the c-fms intronic region
was subject to intragenic transcription. Small RNA molecules
and in particular AS RNAs have been implied in gene silen-
cing and the initiation of heterochromatin formation (Grewal
and Moazed, 2003). To this end, we examined the different
cell types for the presence of AS c-fms RNA using real-time
RT–PCR analysis (Figure 7). To ensure that only AS RNA
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Figure 7 Antisense (AS) RNA starting at FIRE is expressed in macrophages and B cells. (A) Schematic representation of the position of primers
used to carry out cDNA synthesis as well as real-time PCR amplicons. cDNA specific for AS RNA was synthesized from a biotinylated primer
(indicated below the map), whereas an oligo (dT) primer was used to detect spliced transcripts (indicated above the map). Primer sets
(a) (FIRE06) and (b) (30-FIRE) were used to detect AS RNA transcribed from FIRE and from downstream of FIRE, respectively. Primer set (a)
(c-fms QPCR), which is located between exons 12 and 13, was used to detect spliced sense transcripts. Black boxes in the map and numbered
white boxes in the top and bottom map represent c-fms exons. Dashed boxes in the bottom row represent FIRE sequences. The numbers
indicate the nucleotide position relative to the ATG start codon. The localization of the AS transcript is indicated as a horizontal arrow and the
two AS transcription start sites mapped in (C) are indicated. (B) Expression of sense and AS RNA at the c-fms locus as assayed by real-time
PCR. The top panel represents signals obtained with primer pair (a) measuring AS RNA originating from FIRE (1), signals from genomic DNA
contamination (2) (assays with primer pair (a) but without reverse transcriptase) and signals obtained with primer pair (b) (3). The bottom
panel represents spliced sense transcripts detected by primer pair (c). Bars represent mean value7s.d. of two to four independent experiments
analysed in duplicate. (C) Determination of the start site of the AS RNA within FIRE. RT–TDPCR was performed as described in Materials and
methods using RNA prepared from the indicated cell types and from in vitro-synthesized RNA as a control for cDNA synthesis and
amplification artefacts. An RT–TDPCR reaction examining the GAPDH gene was performed as internal control. A sequence reaction was run on
the gel alongside the RT–TDPCR samples and the positions of transcription factor-binding sites within FIRE are indicated. This result was
confirmed in two independently performed experiments.
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molecules were detected, we used biotinylated primers for
cDNA synthesis, bound the reaction products to magnetic
beads and removed excess RNA and contaminating genomic
DNA. To get a first idea of the position of a putative AS
transcription unit and to quantify accurately RNA levels, we
amplified specific regions by real-time PCR using different
sets of primers. All cDNA synthesis reactions were further
controlled by (i) including GAPDH primers to test for RNA
quality, (ii) performing real-time PCR experiments on sam-
ples without reverse transcriptase (RT) and (iii) verifying
the correct fragment size by gel electrophoresis (data not
shown). AS transcription was only found in macrophages and
B cells, but not in fibroblasts and Tcells. The level of AS RNA
was low, but similar in macrophages and B cells, whereas
significant levels of spliced sense transcripts were only
detected in macrophages (Figure 7B). This indicates that AS
transcription in B cells is genuine and does not result from
contamination with myeloid cells. AS RNA was only found
around FIRE. To confirm this finding, the start site of the AS
transcript at FIRE was determined by reverse transcriptase-
terminal transferase-dependent PCR (RT–TDPCR). This
method uses terminal transferase tailing and linker ligation
to amplify cDNA and to identify the start site of low abundant
transcripts (Chen et al, 2000). Two major transcription start
sites within FIRE at þ 2760 and þ 2706 were detected in
macrophages and immature as well as mature B cells, but not
in any other cell types tested (Figure 7C).
Epigenetic c-fms silencing is reversible throughout
B-lymphopoiesis
Our observation of a poised chromatin structure and incom-
plete DNA methylation of c-fms in mature B cells raised the
possibility that c-fms chromatin could be reprogrammed into
the active state in mature B cells. Conditional deletion of the B
cell commitment gene Pax5 was previously shown to re-activate
c-fms expression in pro-B cells (Mikkola et al, 2002). However,
it is not known whether the loss of Pax5 at later stages of B cell
development could also lead to derepression of the c-fms gene.
To address this question, we have taken advantage of the CD19-
cre line, which efficiently deletes a floxed (F) Pax5 allele only in
mature B cells (Horcher et al, 2001). Conditional Pax5 inactiva-
tion in mature B cells of Pax5F/ CD19-cre mice leads to the loss
of Pax5 function and concomitant upregulation of CD25 in
contrast to the B cells of control Pax5F/þCD19-cre mice
(Horcher et al, 2001). We therefore sorted mature Pax5-deficient
(Pax5D/) B cells as CD25þ IgMþ cells from the lymph nodes of
Pax5F/CD19-cre mice after MACS depletion of non-B cells,
whereas control Pax5D/þ B cells were isolated as IgMþ IgDþ
cells from Pax5F/þCD19-cre mice (Supplementary Figure 5).
RT–PCR analysis confirmed that the floxed Pax5 allele
was deleted in all sorted Pax5D/ B cells, leading to the
downregulation of the Pax5 target gene CD19 (Figure 8A)
as previously published (Horcher et al, 2001). Figure 8A
clearly shows that the loss of Pax5 led to re-expression of
the c-fms gene in mature Pax5D/ B cells in contrast to the
control Pax5/þ B cells. Real-time PCR quantification further-
more revealed that the c-fms gene was re-activated to
the same expression level seen in Pax5/ bone marrow
pro-B cells (Figure 8B). These results unequivocally demon-
strate that c-fms silencing in B lymphocytes requires the
continuous presence of Pax5 even at late stages of B cell
differentiation.
Discussion
c-fms cis-regulatory elements are occupied in
pluripotent and restricted haematopoietic precursor
cells
In this paper, we present for the first time in vivo footprinting
experiments with CLPs and with a cell population (LSKs) that
was highly enriched for HSCs and short-term reconstituting
stem cells. LSKs show basically the same degree of transcrip-
tion factor occupancy at the c-fms promoter as CMPs, thus
providing direct confirmation of the hypothesis that the
chromatin of most, and not just a subset, of stem cells and
Figure 8 Epigenetic silencing of c-fms is reversible in mature B
cells. (A) Mature control and Pax5-deficient B cells were isolated
free of contaminating non-B cells from the lymph nodes (LN) of
Pax5F/þ CD19-cre mice (abbreviated as Pax5D/þ ) or Pax5F/CD19-
cre (Pax5D/) mice (Horcher et al, 2001) prior to RNA preparation
and cDNA synthesis as described in Supplementary Figure 5 and
Materials and methods. The cDNA of both cell types was normal-
ized for equal expression of the hypoxanthine phosphoribosyltrans-
ferase (HPRT) gene followed by analysis of the indicated transcripts
by semiquantitative RT–PCR of five-fold serial cDNA dilutions. Pax5
transcripts were amplified from exons 1A to 5. DE2 denotes the
truncated transcript of the Pax5D allele lacking exon 2 in contrast to
the full-length transcript (FL). A PCR artefact consisting of an
FL/DE2 cDNA hybrid is indicated by an asterisk. All PCR fragments
had the correct size, expect for the respective spliced mRNA.
(B) Real-time PCR quantification of c-fms mRNA levels in macro-
phages (M^), sorted lymph node (LN) B cells and in vitro-cultured
bone marrow (BM) pro-B cells of the indicated Pax5 genotypes. The
c-fms mRNA level of the CMP was used as reference, which was
arbitrarily assigned a value of 1.
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early progenitors is primed and accessible to transcription
factor binding. Another important result of our study is that
the c-fms gene is still expressed at low levels in CLPs. This is
in apparent contrast to previous studies that have not de-
tected c-fms mRNA expression in single CLPs that were
purified by the same method (Miyamoto et al, 2002). This
may be because the level of c-fms expression is below the
detection limit of single-cell PCR. More convincingly, we
observed that c-fms transcription factor-binding sites in
CLPs were still occupied by transcription factors, although
the signal was weaker than in CMPs and LSKs. We excluded
the possibility that the signal originated from the small
population of myeloid precursor cells in the sorted population
or from a different level of transcription factors in these cells.
Instead, we believe that transcription factor binding in CLPs
is becoming destabilized, in contrast to cells which are
functionally committed to the myeloid lineage. Support for
the idea that transcription factor action can be dynamic
comes from lineage tracing experiments in which mice carry-
ing a Cre recombinase gene knocked into the myeloid-specific
lysozyme M gene were crossed with ROSA26-EYFP reporter
mice (Ye et al, 2003). These experiments revealed EYFP
expression in non-myeloid cells, indicating that pluripotent
cells giving rise to all myeloid and lymphoid cell types
express the recombinase at a low level at some point in
time. Transplantation experiments with sorted EYFP-negative
cells from such mice showed restoration of EYFP activity,
demonstrating that the expression of Cre recombinase under
the control of the mouse lysozyme M gene is an infrequent but
dynamic event.
Silent chromatin formation at the c-fms locus during
B cell differentiation is a gradual process
Taken together, our results show that epigenetic silencing of
the c-fms locus during lymphopoiesis is a slow process that
begins at the CLP stage. c-fms cis-regulatory regions first lose
transcription factor binding and DNaseI hypersensitivity. In
parallel, mRNA expression from the c-fms promoter ceases
and H3K9 hyperacetylation at the c-fms regulatory region is
reduced. These processes are completed at the pro-B cell
stage. However, at the same stage, not all c-fms chromatin
features have reversed to an inactive state. In contrast to
T cells, B cell precursors and even mature B cells showed
certain chromatin features characteristic of an active locus. In
immature B cells, DNaseI accessibility at the promoter was
still high and levels of H3K4 trimethylation throughout the
intronic regulatory region were elevated. In all B cell types
studied, levels of H3K9 dimethylation were low compared to
fibroblasts, and the region immediately downstream of the
transcription start sites was still MNase hypersensitive. Our
studies of DNA methylation confirmed this idea. Using a
randomly integrated transgene, it was recently shown that
DNA methylation is the last step in gene silencing and slowly
increases during different cell generations (Mutskov and
Felsenfeld, 2004). A similar observation was made with the
mouse Dntt gene that is shut down during the maturation of
immature thymocytes into mature Tcells (Su et al, 2004). The
situation at the c-fms locus appears to be more complex. c-fms
cis-regulatory elements exhibited low DNA methylation levels
in all precursor types and macrophages. However, although
in T-lymphopoiesis DNA at all c-fms elements became sig-
nificantly methylated, it was differentially methylated during
B-lymphopoiesis. CpGs between FIRE and the promoter were
progressively methylated, whereas CpGs at the cores of the
c-fms promoter and FIRE stayed unmethylated throughout.
Experiments from our laboratory indicate that CpGs located
in the centre of critical transcription factor-binding sites but
not in the flanking regions of myeloid-specific genes are the
first to be demethylated during haematopoiesis (Tagoh et al,
2004). A possible role of transcription factors in protecting
DNA from methylation has been reported and may be caused
by an interference of these transcription factors with main-
tenance methylation after DNA synthesis (Mummaneni et al,
1998; Kress et al, 2001; Thomassin et al, 2001). Such transient
interaction cannot be detected by DMS in vivo footprinting
(Lefevre et al, 2003). Therefore, it is tempting to speculate
that differential methylation of the c-fms promoter and FIRE
in B cells and T cells may be caused by transcription factors
(such as PU.1), which are expressed both in macrophages
and B cells.
The c-fms locus contains a differentially regulated
antisense transcription unit
Our experiments revealed the presence of an AS RNA within
the coding region of the c-fms gene starting at the FIRE that is
expressed at low levels in macrophages and B cells. AS RNAs
have been shown to play a role in the regulation of
X-inactivation and genomic imprinting (Lee et al, 1999;
Sleutels et al, 2002). For the human a-globin locus, it was
recently shown that the insertion of an AS promoter next to a
CpG island leads to gene silencing and DNA methylation
(Tufarelli et al, 2003). We do not yet know whether AS RNA
expression is strictly required for c-fms silencing. However,
our extensive analyses of c-fms chromatin and expression are
fully consistent with a regulatory role of the AS transcription
unit. We found that AS transcripts were upregulated by
agonists (LPS, phorbol esters, CSF-1) that repress c-fms
mRNA expression in macrophages (Himes and Hume, manu-
script in preparation). Here, we show that the balance
between sense and AS RNA expression in the c-fms intronic
region is dynamically regulated in different cell types. AS
RNA is expressed at similar levels in both macrophages and B
cells, whereas sense RNA is only expressed in macrophages.
The ratio of sense to AS expression therefore correlates with
c-fms activity. This is in agreement with our previous ob-
servation that FIRE is a dynamic element, which differentially
binds transcription factors in development and associates
with histone acetylases as well as histone deacetylases
(Tagoh et al, 2002; Follows et al, 2003). The data presented
here show most convincingly that the AS transcription unit
overlaps with a region of increased de novo DNA methylation
as well as with areas of elevated H3K4 trimethylation and
H3K9 dimethylation. This raises the interesting possibility
that small double-stranded RNA molecules are formed that
target gene silencing complexes to the c-fms intronic region,
as shown in yeast and Drosophila (Schramke and Allshire,
2003; al-Bhadra et al, 2004; Verdel et al, 2004). The level of
AS transcript was low as compared to the sense transcript.
This is reminiscent of reports from intergenic transcripts
within the b-globin locus that were found at similar low
levels, as they were only expressed at a specific point within
the cell cycle (Gribnau et al, 2000). AS transcription was
absent in T cells and fibroblasts where c-fms chromatin
was shut down. This could indicate a requirement for AS
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transcription to initiate epigenetic silencing, but not for its
maintenance.
c-fms silencing is reversible in B cells
Our chromatin structure studies exclude some possible me-
chanisms by which Pax5 represses c-fms in B cells. The
presence of Pax5 in wild-type B-lineage cells does not cause
remodelling of the promoter nucleosome into the inactive
conformation, it does not induce locus-wide histone H3K9
hypermethylation and it does not induce competitive binding
of Pax5 to cis-regulatory elements and other conserved regions
of the c-fms gene (this study and unpublished observations).
Our experiments point to a mechanism by which Pax5 shifts
the balance between activating and repressing activities re-
cruited to the c-fms locus, and it is likely that this balance needs
to be continuously re-established during B-lymphopoiesis. In
support of this idea, we show here that c-fms expression can be
re-activated not only in pro-B cells (Mikkola et al, 2002) but
also in mature B cells, indicating that the repression of c-fms
requires the continuous presence of Pax5 throughout B cell
differentiation. Our finding that the c-fms locus is not comple-
tely assembled into silent chromatin in mature B cells provides
a molecular explanation for the c-fms re-activation in response
to Pax5 loss and C/EBP overexpression (Xie et al, 2004).
Importantly, the derepression of the c-fms gene in mature
Pax5-deficient cells of the Pax5F/-CD19-cre genotype resulted
in a similar level of c-fms mRNA expression as in Pax5/ pro-
B cells, strongly suggesting that re-activation events occur in
the majority of the mature Pax5-deficient B cells.
Our data link the plasticity of the epigenetic state of the
c-fms gene to a specific chromatin state that is depleted of
activating histone marks (acetylated histones) and even
contains partly methylated DNA, but is still in a poised
conformation. Not only c-fms but also a number of other
lineage-specific genes were activated upon the conditional
inactivation of Pax5 in mature B cells (A Schebesta and M
Busslinger, unpublished observations). It will be interesting
to see whether these genes adopt similar intermediate epige-
netic states in development.
Materials and methods
Purification and RT–PCR analysis of mature Pax5-deficient
B cells
Lymph node cells from Pax5F/þ CD19-cre or Pax5F/CD19-cre mice
(Horcher et al, 2001) were stained with PE-anti-CD8 (53-6.7), CD4
(L3T4), DX5 (DX5), CD11c (HL3), Mac-1 (M1/70), Gr-1 (RB6-8C5),
CD43 (S7) and Ter119 (TER119) antibodies, and non-B cells were
eliminated by magnetic cell sorting with anti-PE MACS beads.
Mature B cells of the Pax5F/þ CD19-cre genotype were subsequently
isolated by FACS sorting as IgMþ IgDþ B cells, and Pax5-deficient
mature B cells of the Pax5F/ CD19-cre genotype were sorted as
IgMþCD25þ B cells (Horcher et al, 2001). Flow cytometric
reanalysis indicated that the sorted cells were free of contaminating
non-B cells (Supplementary Figure 5). RNA was prepared from the
sorted cells and analysed by RT–PCR with previously described
primers (Horcher et al, 2001) except for the c-fms primers.
Detection of antisense RNA
cDNA was synthesized from 2 mg of DNaseI-treated total RNA by
using 400 U of M-MLV reverse transcriptase using biotinylated
primers specific for c-fms (2 pmol) and GAPDH (0.2 pmol) in one
reaction. Synthesized cDNA was immobilized on Dynabeads
(Dynal, M-270). RNA and trace amounts of genomic DNA were
removed by alkaline denaturation and serial washing (Chen et al,
2000). cDNA was eluted by heating the beads suspension in 0.1
TE for 15 min at 991C and was followed by real-time quantitative
PCR. Relative activity was calculated using genomic DNA as a
standard. Input and efficiency of cDNA synthesis was normalized
against GAPDH signals. The amount of spliced transcripts was
calculated using cDNA evaluated as equivalent amount to genomic
DNA.
RT–TDPCR
RT–TDPCR reaction was performed as described previously (Chen
et al, 2000). First strand cDNA was synthesized as described above.
After the immobilization on Dynabeads, cDNA was tailed with three
guanines and ligated to the linker, which contains three cytosines at
the end. The ligated products were PCR-amplified using linker
primer and nested gene-specific primer and visualized by primer
extension reaction using a radiolabelled nested primer. In vitro-
transcribed RNA was prepared from c-fms fragment (þ 849 to
þ 3656) cloned into pBluescriptTMII KSþ using T7 RNA polymer-
ase.
Further previously published methods can be found as Supple-
mentary material. All primer sequences are described in Supple-
mentary Table 1.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
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